Sponsor or institution
Clinical trials and research at Dub Therapeutics INC.
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $2.1 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
A new siRNA therapy to keep trabeculectomy open and prevent scarring
A tiny RNA-based medicine (DUB-001) is being developed to prevent scar tissue from forming after glaucoma surgery, helping more patients keep their eye pressure low.
-
A new treatment to prevent scarring in the cornea
This study is testing a new eye drop treatment that aims to prevent and heal corneal scarring, helping to protect your vision from damage caused by injuries or infections.
-
A new treatment to prevent scarring in the cornea
This study is testing a new eye drop treatment that aims to prevent and heal corneal scarring, which can hurt your vision, by using a special ingredient that targets a specific protein involved in the scarring process.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.